Ask Warren

Iteyes

372800 · KOSDAQ · ₩372800 · 아이티아이즈

₩2,845 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −41.16%
Market cap
₩20B
Enterprise value
₩23B
P/E
—
P/B
1.8×
Dividend yield
0.0%
ROE
−77.9%
Net margin
−12.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−66.8% from the high

₩1,511Today: ₩2,785 – ₩2,890₩8,570

Returns

  • 1W−0.2%
  • 1M−7.9%
  • 3M−1.6%
  • 6M−33.1%
  • YTD−40.7%
  • 1Y−41.2%
Volume today
7,085
0.5× the 20-day average
Traded today
₩20M
Listed shares
7,037,189
EPS (12 months)
−₩1,213
Earnings yield −42.6%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

34Quiet
  • BuzzQuietBuzz 34 of 100 (50 is a normal day for this stock).
  • SentimentPositiveNews: Reports describe a new partnership aimed at growing the business, with no financial figures given. Community: 0 bullish, 0 bearish posts this week.
  • MomentumFlat-3.9% over the last month; the price is above its 20-day average.
  • News impactLow3 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

Iteyes stock overview

Iteyes (아이티아이즈, KRX: 372800) is listed on KOSDAQ, in the Software sector. The company was founded in August 2012 to enter the fintech market and now operates as a specialized IT firm providing financial IT compliance and regulatory response solutions. Its shares closed at ₩2,845 on Oct 29, 2026, unchanged on the day, giving it a market value of ₩20B.

Key facts

Market cap
₩20B
Sector
Software
Latest price change
0.00%
As of
Oct 29, 2026
Main business
The company was founded in August 2012 to enter the fintech market and now operates as a specialized IT firm providing financial IT compliance and regulatory response solutions.

Quick answers about Iteyes

What does Iteyes do?
The company was founded in August 2012 to enter the fintech market and now operates as a specialized IT firm providing financial IT compliance and regulatory response solutions. It is expanding into AI, big data, cloud and blockchain businesses, including its proprietary Vertical AI engine and a medical personal health record data business, as well as a non-face-to-face AI medical care platform. Its products and services serve banks, securities firms, public financial institutions, medical and healthcare sectors, agri-bio fields and public agencies in Korea.
What is the market cap of Iteyes?
The market capitalisation of Iteyes was ₩20B at the close on Oct 29, 2026.
Who are the largest shareholders of Iteyes?
According to the latest official filings, the largest reported holders are Lee Sung-nam (51.17%, as of Sep 2, 2026); Song Deok-su (15.03%, as of Apr 15, 2026); Fine Value Asset Management (4.55%, as of Jul 3, 2026).
When is the next earnings report from Iteyes?
Korean companies rarely announce results dates in advance. Based on when Iteyes filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.

Company profile

The company was founded in August 2012 to enter the fintech market and now operates as a specialized IT firm providing financial IT compliance and regulatory response solutions. It is expanding into AI, big data, cloud and blockchain businesses, including its proprietary Vertical AI engine and a medical personal health record data business, as well as a non-face-to-face AI medical care platform. Its products and services serve banks, securities firms, public financial institutions, medical and healthcare sectors, agri-bio fields and public agencies in Korea.

Written by AI from the company's latest annual report.

Korean name
아이티아이즈
Sector
Software
Themes
Software & cloud
CEO
이성남
Founded
Aug 2012
Listed
Nov 2021
Listed shares
7,037,189
Fiscal year ends
Month 12
Website
www.iteyes.co.kr/

Similar companies

Recent news

News · Etoday·

Iteyes Partners with Cable Blue Bio and Advanced Precision Medicine Industrialization Support Center on AI Cancer Diagnosis Development

Iteyes₩2,8450.00%
Read the original ↗

Predicted impact: Low

Same three-party MOU on AI cancer diagnosis already reported; non-binding and no financial size.

News · Money Today·

Iteyes Signs Three-Party MOU for Cancer Diagnosis Based on 'Jenai Me' to Accelerate Precision Medicine Business

Iteyes₩2,8450.00%
Read the original ↗

Predicted impact: Low

Three-party MOU for AI cancer diagnosis; small, vague, and already reported in the past 14 days.

News · Asia Economy·

Iteyes signs three-party MOU, aiming to develop AI-based cancer diagnosis solution

Iteyes₩2,8450.00%
Read the original ↗

Predicted impact: Low

Three-party MOU for AI cancer diagnosis; no contract value or revenue share given.

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Iteyes / 아이티아이즈 / 372800 / KRX:372800

Source: KRX statistical information